JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
The world's biggest healthcare products maker continued with its long streak of earnings beat but lagged revenue estimates. JNJ shares declined 2.1% on the day and ETFs having the largest allocation to this diversified drug maker are in focus. These include iShares U.S. Pharmaceuticals ETF IHE, iShares U.S. Healthcare ETF IYH, First Trust Nasdaq Pharmaceuticals ETF FTXH, Health Care Select Sector SPDR Fund XLV and VanEck Vectors Pharmaceutical ETF PPH. Earnings per share came in at $2.71, beating the Zacks Consensus Estimate of $2.64 and improving 12.4% from the year-ago quarter. Revenues grew 2% year over year to $21.38 billion and fell short of the Zacks Consensus Estimate of $21.4 billion (see: all the Healthcare ETFs here). Innovative Medicines sales advanced 8.3%, while sales from MedTech devices jumped 6.3%. Sales of JNJ's top-selling blood cancer treatment, Darzalex, jumped about 19% to $2.69 billion. The cancer drug is expected to bring in sales of more than $11 billion
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson Is a King of Dividend Safety [Yahoo! Finance]Yahoo! Finance
- Ethereum price today: ETH is trading at $3,159.52 [USA TODAY]USA TODAY
- Johnson & Johnson's (NYSE:JNJ) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? [Yahoo! Finance]Yahoo! Finance
- 3 Unusual Income ETFs That May Be Just What You're Looking For [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/29/24 - Form 4
- 4/29/24 - Form 4
- 4/29/24 - Form 4
- JNJ's page on the SEC website